Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP Trial
NCT06412757Phase 3Recruiting
- Sponsor
- Deakin University
- Start
- Aug 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Silexan in post-traumatic stress disorder (PTSD), sponsored by Deakin University. Started Aug 2024; status: recruiting.
02
Drugs
Silexan
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06412757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06412757.